Electric shocks plus chemo: new hope for rare tumor patients?

NCT ID NCT06660121

First seen Jan 02, 2026 · Last updated May 07, 2026 · Updated 14 times

Summary

This study looks at whether electrochemotherapy (ECT) can shrink desmoid fibromatosis tumors and improve symptoms. About 30 people with growing, painful tumors who cannot have surgery or other treatments will receive ECT. Researchers will track tumor size with MRI and quality of life with questionnaires for one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DESMOID FIBROMATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS Istituto Ortopedico Rizzoli

    RECRUITING

    Bologna, 40136, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.